222 related articles for article (PubMed ID: 18451162)
1. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.
Guo Y; Xie J; Rubin E; Tang YX; Lin F; Zi X; Hoang BH
Cancer Res; 2008 May; 68(9):3350-60. PubMed ID: 18451162
[TBL] [Abstract][Full Text] [Related]
2. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
Zi X; Guo Y; Simoneau AR; Hope C; Xie J; Holcombe RF; Hoang BH
Cancer Res; 2005 Nov; 65(21):9762-70. PubMed ID: 16266997
[TBL] [Abstract][Full Text] [Related]
3. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells.
Guo Y; Zi X; Koontz Z; Kim A; Xie J; Gorlick R; Holcombe RF; Hoang BH
J Orthop Res; 2007 Jul; 25(7):964-71. PubMed ID: 17318900
[TBL] [Abstract][Full Text] [Related]
4. [Effects of FRZB on growth and metastasis of gastric cancer cell line SGC-7901].
Qu Y; Li JF; Cai Q; Liu BY; Zhu ZG
Ai Zheng; 2008 Aug; 27(8):795-802. PubMed ID: 18710611
[TBL] [Abstract][Full Text] [Related]
5. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
7. FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer.
Qin S; Zhang Z; Li J; Zang L
Oncol Rep; 2014 May; 31(5):2351-7. PubMed ID: 24676361
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
9. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
Ji T; Guo Y; Kim K; McQueen P; Ghaffar S; Christ A; Lin C; Eskander R; Zi X; Hoang BH
Mol Cancer; 2015 Apr; 14():86. PubMed ID: 25890345
[TBL] [Abstract][Full Text] [Related]
11. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
[TBL] [Abstract][Full Text] [Related]
12. The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis.
Enomoto-Iwamoto M; Kitagaki J; Koyama E; Tamamura Y; Wu C; Kanatani N; Koike T; Okada H; Komori T; Yoneda T; Church V; Francis-West PH; Kurisu K; Nohno T; Pacifici M; Iwamoto M
Dev Biol; 2002 Nov; 251(1):142-56. PubMed ID: 12413904
[TBL] [Abstract][Full Text] [Related]
13. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
14. RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival.
Shinomiya N; Gao CF; Xie Q; Gustafson M; Waters DJ; Zhang YW; Vande Woude GF
Cancer Res; 2004 Nov; 64(21):7962-70. PubMed ID: 15520203
[TBL] [Abstract][Full Text] [Related]
15. Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells.
Jensen AR; David SY; Liao C; Dai J; Keller ET; Al-Ahmadie H; Dakin-Haché K; Usatyuk P; Sievert MF; Paner GP; Yala S; Cervantes GM; Natarajan V; Salgia R; Posadas EM
Clin Cancer Res; 2011 May; 17(10):3112-22. PubMed ID: 21364031
[TBL] [Abstract][Full Text] [Related]
16. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
17. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.
Wang H; Fan L; Xia X; Rao Y; Ma Q; Yang J; Lu Y; Wang C; Ma D; Huang X
Int J Gynecol Cancer; 2012 Jun; 22(5):755-61. PubMed ID: 22635028
[TBL] [Abstract][Full Text] [Related]
18. Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.
Garg M; Kanojia D; Okamoto R; Jain S; Madan V; Chien W; Sampath A; Ding LW; Xuan M; Said JW; Doan NB; Liu LZ; Yang H; Gery S; Braunstein GD; Koeffler HP
J Clin Endocrinol Metab; 2014 Jan; 99(1):E62-72. PubMed ID: 24170107
[TBL] [Abstract][Full Text] [Related]
19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
20. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
